Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2000-11-28
2003-07-08
Raymond, Richard L. (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S450000, C540S541000, C540S465000, C556S032000, C556S045000
Reexamination Certificate
active
06589948
ABSTRACT:
FIELD OF THE INVENTION
The present invention provides, inter alia, antioxidant compositions, including pharmaceutical compositions, of synthetic catalytic cyclic salen-metal antioxidants and reactive oxygen species scavengers for therapy and prophylaxis of disease and prevention of oxyradical-mediated oxidation; methods of using such cyclic salen-metal antioxidants in the prevention and treatment of pathological conditions; methods of using such cyclic salen-metal antioxidants as preservatives and oxyradical quenching agents; methods of using such cyclic salen-metal antioxidants for targeted protection of tissues and/or cell types during cancer chemotherapy; and methods of using such cyclic salen-metal antioxidants to prevent toxicologic damage to individuals exposed to irritating oxidants or other sources of oxidative damage, particularly oxygen-derived oxidative species, such as the superoxide radical and hydrogen peroxide. In addition, the present invention provides compositions and methods that are useful for preventing oxidative damage in human transplant organs and for inhibiting reoxygenration injury following reperfusion of ischemic tissues. In addition, the present invention provides compositions and methods that are useful for chemoprevention of chemical carcinogenesis and alteration of drug metabolism involving epoxide or free oxygen radical intermediates. The present invention also provides novel cyclic salen-metal compounds (CSMCs) having therapeutically useful catalytic properties, and compositions containing such novel compounds.
BACKGROUND OF THE INVENTION
Molecular oxygen is an essential nutrient for nonfacultative aerobic organisms, including, of course, humans. Oxygen is used in many important ways, namely, as the terminal electronic acceptor in oxidative phosphorylation, in many dioxygenase reactions, including the synthesis of prostaglandins and of vitamin A from carotenoids, in a host of hydroxylase reactions, including the formation and modification of steroid hormones, and in both the activation and the inactivation of xenobiotics, including carcinogens. The extensive P-450 system uses molecular oxygen in a host of important cellular reactions. In a similar vein, nature employs free radicals in a large variety of enzymic reactions.
Excessive concentrations of various forms of reactive oxygen species and of free radicals can have serious adverse effects on living systems, including the peroxidation of membrane lipids, the hydroxylation of nucleic acid bases, and the oxidation of sulthydryl groups and of other sensitive moieties in proteins. If uncontrolled, mutations and/or cellular death result.
Biological antioxidants include well-defined enzymes, such as superoxide dismutase, catalase, selenium glutathione peroxidase, and phospholipid hydroperoxide glutathione peroxidase. Nonenzymatic biological antioxidants include tocopherols and tocotrienols, carotenoids, quinones, bilirubin, ascorbic acid, uric acid, and metal-binding proteins. Various antioxidants, being both lipid and water soluble, are found in all parts of cells and tissues, although each specific antioxidant often shows a characteristic distribution pattern. The so-called ovothiols, which are mercaptohistidine derivatives, also decompose peroxides nonenzymatically.
Free radicals, particularly free radicals derived from molecular oxygen, are believed to play a fundamental role in a wide variety of biological phenomena. In fact, it has been suggested that much of what is considered critical illness may involve oxygen radical (“oxyradical”) pathophysiology (Zimmerman, J. J. (1991)
Chest
00:1895). Oxyradical injury has been implicated in the pathogenesis of pulmonary oxygen toxicity, adult respiratory distress syndrome (ARDS), bronchopulmonary dysplasia, sepsis syndrome, and a variety of ischemia-reperfusion syndromes, including myocardial infarction, stroke, cardiopulmonary bypass, organ transplantation, necrotizing enterocolitis, acute renal tubular necrosis, and other disease. Oxyradicals can react with proteins, nucleic acids, lipids, and other biological macromolecules producing damage to cells and tissues, particularly in the critically ill patient.
Free radicals are atoms, ions, or molecules that contain an unpaired electron (Pryor, W. A. (1976)
Free Radicals in Biol.
1:1). Free radicals are usually unstable and exhibit short half-lives. Elemental oxygen is highly electronegative and readily accepts single electron transfers from cytochromes and other reduced cellular components; a portion of the O
2
consumed by cells engaged in aerobic respiration is univalently reduced to superoxide radical (i.e., .O
2
−
) (Cadenas, E. (1989)
Ann. Rev. Biochem.
58:79). Sequential univalent reduction of .O
2
−
produces hydrogen peroxide (i.e., H
2
O
2
), a hydroxyl radical (i.e., .OH), and water.
Free radicals can originate from many sources, including aerobic respiration, cytochrome P-450-catalyzed monooxygenation reactions of drugs and xenobiotics (e.g., trichloromethyl radicals, i.e., CCl
3
., formed from oxidation of carbon tetrachloride), and ionizing radiation. For example, when tissues are exposed to gamma radiation, most of the energy deposited in the cells is absorbed by water and results in scission of the oxygen-hydrogen covalent bonds in water, leaving a single electron on hydrogen and one on oxygen, thereby creating two radicals, i.e., H. and .OH. The hydroxyl radical, i.e., .OH, is the most reactive radical known in chemistry. It reacts with biomolecules, sets off chain reactions and can interact with the purine or pyrimidine bases of nucleic acids. Indeed, radiation-induced carcinogenesis may be initiated by free radical damage (Breimer, L. H. (1988)
Brit. J Cancer
57:6). In addition, the “oxidative burst” of activated neutrophils produces abundant superoxide radical, which is believed to be an essential factor in producing the cytotoxic effect of activated neutrophils. Reperfusion of ischemic tissues also produces large concentrations of oxyradicals, typically superoxide (Gutteridge and Halliwell (1990)
Arch. Biochem. Biophys.
283:223). Moreover, superoxide can be produced physiologically by endothelial cells for reaction with nitric oxide, a physiological regulator, forming peroxynitrite, i.e., ONOO
−
which may decay and give rise to hydroxyl radical, .OH (Marletta, M. A. (1989)
Trends Biochem. Sci.
14:488; Moncada, et al. (1989)
Biochem. Pharmacol.
38:1709; Saran, et al. (1990)
Free Rad. Res. Commun.
10:221; Beckman, et al. (1990)
Proc. Natl. Acad. Sci. (U.S.A.)
87:1620). Additional sources of oxyradicals are “leakage” of electrons from disrupted mitochondrial or endoplasmic reticular electron transport chains, prostaglandin synthesis, oxidation of catecholamines, and platelet activation.
Oxygen, though essential for aerobic metabolism, can be converted to poisonous metabolites, such as the superoxide anion and hydrogen peroxide, collectively known as reactive oxygen species (ROS). Increased ROS formation under pathological conditions is believed to cause cellular damage through the action of these highly reactive molecules on proteins, lipids, and DNA. During inflammation, ROS are generated by activated phagocytic leukocytes. As described above; during the neutrophil “respiratory burst,” superoxide anion is generated by the membrane-bound NADPH oxidase. ROS are also believed to accumulate when tissues are subjected to ischemia followed by reperfusion.
Many free radical reactions are highly damaging to cellular components, i.e., they crosslink proteins, mutagenize DNA, and peroxidize lipids. Once formed, free radicals can interact to produce other free radicals and non-radical oxidants such as singlet oxygen (
1
O
2
) and peroxides. Degradation of some of the products of free radical reactions can also generate potentially damaging chemical species. For example, malondialdehyde is a reaction product of peroxidized lipids that reacts with virtually any amnine-containing molecule. Oxygen free radicals also cause oxidative modification of proteins (St
Doctrow Susan
Malfroy-Camine Bernard
Eukarion, Inc.
Habte Kahsay
Raymond Richard L.
Townsend & Townsend & Crew LLP
LandOfFree
Cyclic salen-metal compounds: reactive oxygen species... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Cyclic salen-metal compounds: reactive oxygen species..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cyclic salen-metal compounds: reactive oxygen species... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3073132